Literature DB >> 3082923

Reaction pattern of human anti-Mycoplasma pneumoniae antibodies in enzyme-linked immunosorbent assays and immunoblotting.

E Jacobs, A Bennewitz, W Bredt.   

Abstract

In serological diagnosis of Mycoplasma pneumoniae disease the frequently used complement fixation test is based on a cross-reacting glycolipid. Recently enzyme-linked immunoassays have been developed to overcome this lack of specificity. To study the involvement of the various proteins and the influence of age on the level of antiprotein antibodies present, we investigated by enzyme-linked immunoassays (immunoglobulin M [IgM] and IgG) and immunoblotting the sera of healthy persons of different age groups as well as sera of patients (including paired sera) with M. pneumoniae infection. In sera of children with nonrespiratory diseases and in healthy blood donors the IgM antibodies rose during the first 2 years of life to a relatively constant background level (optical density at 405 nm of 0.15 to 0.21). In contrast IgG remained low up to the seventh year and then increased to moderate levels (optical density of 0.15). The blotting patterns showed few IgM bands in the age group of 20 to 30 years. IgG blots revealed, up to 7 years, only very few reactions with a 168-kilodalton protein, but in higher age groups a considerable number of reactions with proteins of 193, 168, 84, 69, and 56 kilodaltons were detected. In the sera of patients, positive IgM blots were most numerous in the third week, whereas the number of IgG blots increased up to the fourth and the fifth week. At this time all sera contained antibodies against the 168-kilodalton protein, which is identical with the adhesin of M. pneumoniae. In a patient with acute infection, who had a high preinfection IgG level, no IgM response developed. The data indicate a relatively high background of antibodies against M. pneumoniae proteins in older age groups, suggesting a requirement for paired sera. Furthermore, reinfections of adults may occur without a concomitant IgM response.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082923      PMCID: PMC268686          DOI: 10.1128/jcm.23.3.517-522.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

2.  Protective Effect of Vaccines in Experimental Mycoplasma pneumoniae Disease.

Authors:  G W Fernald; W A Clyde
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

3.  Immunological relationships between Mycoplasma pneumoniae and Streptococcus MG.

Authors:  K Lind
Journal:  Acta Pathol Microbiol Scand       Date:  1968

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Mycoplasma pneumoniae adhesin localized to tip structure by monoclonal antibody.

Authors:  J Feldner; U Göbel; W Bredt
Journal:  Nature       Date:  1982-08-19       Impact factor: 49.962

6.  Use of the enzyme-linked immunosorbent assay for the early diagnosis of Mycoplasma pneumoniae infection.

Authors:  A J van Griethuysen; R de Graaf; J A van Druten; F W Heessen; J T van der Logt; A M van Loon
Journal:  Eur J Clin Microbiol       Date:  1984-04       Impact factor: 3.267

7.  Relationship of pre-existing antibody to subsequent infection by Mycoplasma pneumoniae in adults.

Authors:  D P McCormick; R P Wenzel; L B Senterfit; W E Beam
Journal:  Infect Immun       Date:  1974-01       Impact factor: 3.441

8.  Protective efficacy of Mycoplasma pneumoniae polysaccharides.

Authors:  H Brunner
Journal:  Isr J Med Sci       Date:  1981-07

9.  Immunoglobulin M antibody response against Mycoplasma pneumoniae lipid antigen in patients with acute pancreatitis.

Authors:  P O Leinikki; P Panzar; H Tykkä
Journal:  J Clin Microbiol       Date:  1978-08       Impact factor: 5.948

10.  Host discrimination of Mycoplasma pneumoniae proteinaceous immunogens.

Authors:  D K Leith; L B Trevino; J G Tully; L B Senterfit; J B Baseman
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more
  25 in total

1.  Indirect enzyme-linked immunosorbent assay for detection of immunoglobulin G reactive with a recombinant protein expressed from the gene encoding the 116-kilodalton protein of Mycoplasma pneumoniae.

Authors:  M F Duffy; K G Whithear; A H Noormohammadi; P F Markham; M Catton; J Leydon; G F Browning
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

2.  Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard".

Authors:  Matthias F C Beersma; Kristien Dirven; Alje P van Dam; Kate E Templeton; Eric C J Claas; Herman Goossens
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

3.  A B cell-, T cell-linked epitope located on the adhesin of Mycoplasma pneumoniae.

Authors:  E Jacobs; R Röck; L Dalehite
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

4.  A 168-kilodalton protein of Mycoplasma pneumoniae used as antigen in a dot enzyme-linked immunosorbent assay.

Authors:  E Jacobs; K Fuchte; W Bredt
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

5.  Molecular approaches to diagnosis of pulmonary diseases due to Mycoplasma pneumoniae.

Authors:  M Abele-Horn; U Busch; H Nitschko; E Jacobs; R Bax; F Pfaff; B Schaffer; J Heesemann
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

6.  Enzyme immunoassay for detection of immunoglobulin M (IgM) and IgG antibodies to Mycoplasma pneumoniae.

Authors:  S A Uldum; J S Jensen; J Søndergård-Andersen; K Lind
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

7.  Rapid immunoblot method for diagnosis of acute Mycoplasma pneumoniae infection.

Authors:  N Cimolai; D Mah; E Thomas; P J Middleton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

8.  Evaluation of a commercial enzyme immunoassay for detection of Mycoplasma pneumoniae specific immunoglobulin G antibodies.

Authors:  S A Uldum; J Søndergård-Andersen; J Skov Jensen; K Lind
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

9.  Binding sites of attachment-inhibiting monoclonal antibodies and antibodies from patients on peptide fragments of the Mycoplasma pneumoniae adhesin.

Authors:  E Jacobs; B Gerstenecker; B Mader; C H Huang; P C Hu; R Halter; W Bredt
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

10.  Are outbreaks and sporadic respiratory infections by Mycoplasma pneumoniae due to two distinct subtypes?

Authors:  E Jacobs; M Vonski; K Oberle; O Opitz; K Pietsch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.